Apolipoprotein A-IV is a candidate target molecule for the treatment of seasonal allergic rhinitis.
Makino Y, Noguchi E, Takahashi N, Matsumoto Y, Kubo S, Yamada T, Imoto Y, Ito Y, Osawa Y, Shibasaki M, Uchida K, Meno K, Suzuki H, Okubo K, Arinami T, Fujieda S.
Makino Y, et al. Among authors: ito y.
J Allergy Clin Immunol. 2010 Dec;126(6):1163-9.e5. doi: 10.1016/j.jaci.2010.06.031.
J Allergy Clin Immunol. 2010.
PMID: 20810159
Clinical Trial.